Short Wave Folgen

We're continuing our celebration of taste with another episode in our "Taste Buddies" series. Today: Umami.In the early 1900s a Japanese chemist identified umami, but it took a century for his work to be translated into English. In this encore episode, Short Wave host Emily Kwong talks with producer Chloee Weiner about why it took so long for umami to be recognized as the fifth taste.Follow Emily on Twitter @emilykwong1234. Reach the show by sending an email to ShortWave@NPR.org.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

This week Short Wave is celebrating our sense of taste with an entire week of themed episodes, covering everything from sugar and spice to what's beyond our classic ideas of taste. It's a series we're calling, "Taste Buddies."In today's encore episode with Atlantic science writer Katherine Wu, we take a tour through the mysteries of sourness — complete with a fun taste test. Along the way, Katie serves up some hypotheses for the evolution of sour taste because, as Katie explains in her article, "The Paradox of Sour," researchers still have a lot to learn about this weird taste.Baffled by another seemingly mundane aspect of our existence? Email the show at shortwave@npr.org and who knows — it might turn into a whole series!See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

The Food and Drug Administration allows faster drug approvals based on preliminary study data if the drug fulfills an unmet medical need. But the speedy approval comes with a promise that the drugmaker does another clinical trial once the drug is on the market to prove it really works. If not, the FDA can rescind the approval. How are the companies doing and how well does the agency enforce that system? Pharmaceuticals correspondent Sydney Lupkin investigated the 30-year track record for accelerated approvals. Today, her findings on stalled trials and missing evidence.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy